ERAS vs. SAF.PA
ERAS (Erasca, Inc.) and SAF.PA (Safran SA) are both stocks. ERAS operates in Biotechnology (Healthcare), while SAF.PA operates in Aerospace & Defense (Industrials). Over the past 3 years, ERAS returned 63.40%/yr vs 34.81%/yr for SAF.PA. At a 0.12 correlation, their price movements are largely independent.
Performance
ERAS vs. SAF.PA - Performance Comparison
Loading charts...
Different Trading Currencies
ERAS is traded in USD, while SAF.PA is traded in EUR. To make them comparable, the SAF.PA values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, ERAS achieves a 245.97% return, which is significantly higher than SAF.PA's 0.94% return.
ERAS
- 1D
- 7.52%
- 1M
- 27.17%
- YTD
- 245.97%
- 6M
- 285.33%
- 1Y
- 704.37%
- 3Y*
- 63.40%
- 5Y*
- —
- 10Y*
- —
SAF.PA
- 1D
- 2.32%
- 1M
- 4.50%
- YTD
- 0.94%
- 6M
- 3.39%
- 1Y
- 16.48%
- 3Y*
- 34.81%
- 5Y*
- 19.65%
- 10Y*
- 18.67%
ERAS vs. SAF.PA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ERAS Erasca, Inc. | 245.97% | 48.21% | 17.84% | -50.58% | -72.34% | -10.61% |
SAF.PA Safran SA | 0.94% | 60.85% | 26.05% | 42.07% | 2.59% | -8.53% |
Correlation
The correlation between ERAS and SAF.PA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jul 19, 2021 | 0.12 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ERAS vs. SAF.PA — Risk / Return Rank
ERAS
SAF.PA
ERAS vs. SAF.PA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Erasca, Inc. (ERAS) and Safran SA (SAF.PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ERAS | SAF.PA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +6.33 | ||
| Sortino ratioReturn per unit of downside risk | +3.20 | ||
| Omega ratioGain probability vs. loss probability | 1.66 | 1.12 | +0.54 |
| Calmar ratioReturn relative to maximum drawdown | 11.96 | 0.67 | +11.29 |
| Martin ratioReturn relative to average drawdown | 38.13 | 1.80 | +36.33 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ERAS | SAF.PA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 6.83 | 0.50 | +6.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.64 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.53 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.07 | 0.45 | -0.53 |
Drawdowns
ERAS vs. SAF.PA - Drawdown Comparison
The maximum ERAS drawdown since its inception was -95.65%, which is greater than SAF.PA's maximum drawdown of -65.85%. Use the drawdown chart below to compare losses from any high point for ERAS and SAF.PA.
Loading charts...
Drawdown Indicators
| ERAS | SAF.PA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.65% | -65.85% | -29.80% |
Max Drawdown (1Y)Largest decline over 1 year | -59.46% | -24.21% | -35.25% |
Max Drawdown (3Y)Largest decline over 3 years | -67.68% | -24.21% | -43.47% |
Max Drawdown (5Y)Largest decline over 5 years | — | -41.76% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -65.00% | — |
Current DrawdownCurrent decline from peak | -47.12% | -13.82% | -33.30% |
Average DrawdownAverage peak-to-trough decline | -74.82% | -13.89% | -60.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.61% | 9.01% | +9.60% |
Volatility
ERAS vs. SAF.PA - Volatility Comparison
Erasca, Inc. (ERAS) has a higher volatility of 20.75% compared to Safran SA (SAF.PA) at 10.60%. This indicates that ERAS's price experiences larger fluctuations and is considered to be riskier than SAF.PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ERAS | SAF.PA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.75% | 10.60% | +10.15% |
Volatility (6M)Calculated over the trailing 6-month period | 96.00% | 28.77% | +67.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.32% | 32.42% | +71.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.42% | 30.36% | +53.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.42% | 34.60% | +48.82% |
Dividends
ERAS vs. SAF.PA - Dividend Comparison
ERAS has not paid dividends to shareholders, while SAF.PA's dividend yield for the trailing twelve months is around 1.12%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ERAS Erasca, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SAF.PA Safran SA | 1.12% | 0.98% | 1.04% | 0.85% | 0.43% | 0.40% | 0.00% | 1.32% | 1.53% | 0.97% | 2.15% | 1.96% |
Financials
ERAS vs. SAF.PA - Financials Comparison
This section allows you to compare key financial metrics between Erasca, Inc. and Safran SA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ERAS and SAF.PA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ERAS and SAF.PA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer